DD124102A5 - - Google Patents

Info

Publication number
DD124102A5
DD124102A5 DD191877A DD19187776A DD124102A5 DD 124102 A5 DD124102 A5 DD 124102A5 DD 191877 A DD191877 A DD 191877A DD 19187776 A DD19187776 A DD 19187776A DD 124102 A5 DD124102 A5 DD 124102A5
Authority
DD
German Democratic Republic
Application number
DD191877A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of DD124102A5 publication Critical patent/DD124102A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD191877A 1975-03-17 1976-03-16 DD124102A5 (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
DD124102A5 true DD124102A5 (enExample) 1977-02-02

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
DD191877A DD124102A5 (enExample) 1975-03-17 1976-03-16

Country Status (21)

Country Link
JP (1) JPS51115910A (enExample)
AR (1) AR222624A1 (enExample)
AT (1) AT353415B (enExample)
AU (1) AU505355B2 (enExample)
CA (1) CA1073358A (enExample)
CH (1) CH630257A5 (enExample)
DD (1) DD124102A5 (enExample)
DE (1) DE2611041A1 (enExample)
DK (1) DK148344C (enExample)
ES (1) ES446075A1 (enExample)
FR (1) FR2304354A1 (enExample)
GB (1) GB1546448A (enExample)
GR (1) GR60341B (enExample)
IE (1) IE43083B1 (enExample)
LU (1) LU74558A1 (enExample)
MC (1) MC1101A1 (enExample)
NL (1) NL190313C (enExample)
NZ (1) NZ180321A (enExample)
PH (1) PH14927A (enExample)
PT (1) PT64907B (enExample)
SE (1) SE433804B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
CA2107678A1 (en) * 1991-04-08 1992-10-09 Kouichi Nakamichi Capsule
CA2132012C (en) * 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
AU8000494A (en) * 1993-10-29 1995-05-22 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
AU692483B2 (en) * 1993-10-29 1998-06-11 R.P. Scherer Corporation Gelatin capsule fill able to foam
CA2190188A1 (en) * 1994-05-13 1995-11-23 Prasad S. Adusumilli Method and composition for increasing calcium uptake
MX9704043A (es) * 1994-12-01 1998-02-28 Cibus Pharmaceuticals Inc Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine
WO2026022379A1 (en) * 2024-07-26 2026-01-29 Inkvivo Technologies Sa Gastroretentive formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (enExample) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
IE43083L (en) 1976-09-17
PT64907A (fr) 1976-04-01
AU505355B2 (en) 1979-11-15
SE433804B (sv) 1984-06-18
JPS638084B2 (enExample) 1988-02-19
NZ180321A (en) 1978-06-20
DK148344C (da) 1985-11-04
AR222624A1 (es) 1981-06-15
ES446075A1 (es) 1977-09-16
DK113676A (da) 1976-09-18
NL7602776A (nl) 1976-09-21
MC1101A1 (fr) 1977-02-04
CA1073358A (en) 1980-03-11
DK148344B (da) 1985-06-17
PT64907B (fr) 1978-03-24
GR60341B (en) 1978-05-17
PH14927A (en) 1982-01-29
AT353415B (de) 1979-11-12
IE43083B1 (en) 1980-12-17
DE2611041C2 (enExample) 1988-06-09
ATA192276A (de) 1979-04-15
SE7603325L (sv) 1976-09-18
NL190313C (nl) 1994-01-17
JPS51115910A (en) 1976-10-13
FR2304354B1 (enExample) 1979-04-27
GB1546448A (en) 1979-05-23
AU1204976A (en) 1977-09-22
DE2611041A1 (de) 1976-10-14
CH630257A5 (en) 1982-06-15
NL190313B (nl) 1993-08-16
LU74558A1 (enExample) 1977-09-27
FR2304354A1 (fr) 1976-10-15

Similar Documents

Publication Publication Date Title
FR2304354B1 (enExample)
FR2331301B3 (enExample)
JPS567261B2 (enExample)
JPS51139871U (enExample)
JPS5214552U (enExample)
JPS5240383U (enExample)
JPS5217360U (enExample)
JPS51146837U (enExample)
CH594217A5 (enExample)
CH594203A5 (enExample)
CH601976A5 (enExample)
CH600083A5 (enExample)
BG23337A1 (enExample)
CH588401A5 (enExample)
BG23066A1 (enExample)
CH599384A5 (enExample)
CH603263A5 (enExample)
CH581241A5 (enExample)
CH597036A5 (enExample)
CH602830A5 (enExample)
CH599265A5 (enExample)
BG21530A1 (enExample)
BG22254A1 (enExample)
DD122445A1 (enExample)
CH599019A5 (enExample)